LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Начало・Списък с акции・Celsion Corp

Celsion Corp

Отворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Служители	25

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+669.23% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	938K
Предишно отваряне	0
Предишно затваряне	0

Celsion Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.02.2026 г., 22:17 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP 1st Half Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

16.02.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

16.02.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Decline; Prime Minister Takaichi's Policy Steps in Focus -- Market Talk

16.02.2026 г., 23:23 ч. UTC

Придобивния, сливания и поглъщания

BHP Shares Up 7.0% After Silver Streaming Deal, Profit Beat

16.02.2026 г., 23:20 ч. UTC

Придобивния, сливания и поглъщания

BHP Exploring Other Infrastructure Deals as It Chases $10 Billion Target - Interview

16.02.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Brokers Value BHP's Total Stake in Antamina Around $4.5 Billion

16.02.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Has Desalination, Other Power Assets on Which Deals Could Be Considered

16.02.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Wants to Make Sure It Does Not Give Up Any Strategic, Operational Control of Assets

16.02.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Will Allocate Cash From Asset Deals to Growth, Shareholder Returns

16.02.2026 г., 22:47 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Won't Put Deadline on $10 Billion Cash Unlock Target

16.02.2026 г., 22:47 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Bar Very High For Asset Deals

16.02.2026 г., 22:47 ч. UTC

Придобивния, сливания и поглъщания

BHP CFO: Sees 'Quite a Lot of Opportunities' in Potential Infrastructure Deals

16.02.2026 г., 22:35 ч. UTC

Пазарно говорене

Australian Jobs Data Could Confirm Market Too Tight -- Market Talk

16.02.2026 г., 22:02 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP 1H Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

16.02.2026 г., 21:48 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP: Optimistic That Economic Backdrop Supportive For Key Commodities

16.02.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

Wheaton Precious Metals: Acquisition Immediately Increases Production and Cash Flow Profile

16.02.2026 г., 21:48 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP: China's Economy Resilient; India Continues to Outperform

16.02.2026 г., 21:47 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP: Streaming, WAIO Power Deals Unlock Over $6 Billion of Cash Combined

16.02.2026 г., 21:47 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP: Sees Potential to Unlock Up to $10 Billion From Portfolio, Asset Management

16.02.2026 г., 21:47 ч. UTC

Придобивния, сливания и поглъщания

Wheaton Precious Metals to Have Combined 67.5% of All the Silver Produced From Antamina, Up From 33.75% Currently

16.02.2026 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Wheaton Precious Metals: Upfront Payment to Be Funded Through Combination of Existing Liquidity and New Financing

16.02.2026 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Wheaton Precious Metals Will Pay BHP Total Upfront Cash Consideration of $4.3B on Closing

16.02.2026 г., 21:46 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP Interim Dividend Represents 60% Payout Ratio

16.02.2026 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Wheaton Precious Metals in Definitive Precious Metals Purchase Agreement BHP Subsidiary for Its 33.75% Portion of Silver Produced at Antamina Mine in Peru

16.02.2026 г., 21:45 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP: Copper Contributed 51% of 1H Underlying Ebitda

16.02.2026 г., 21:43 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP Net Debt $14.69 Billion at Dec. 31, Up 25% On-Year

16.02.2026 г., 21:43 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP 1H Net Operating Cash Flow $9.37 Billion, Up 13% On-Year

16.02.2026 г., 21:42 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP 1H Underlying Ebitda $15.46 Billion, Up 25% On-Year

16.02.2026 г., 21:42 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP Was Expected to Record Underlying Profit of $6.03 Billion According to Visible Alpha

16.02.2026 г., 21:41 ч. UTC

Печалби

Придобивния, сливания и поглъщания

BHP 1H Underlying Profit $6.20 Billion, Up 22% On-Year

Сравнение с други в отрасъла

Ценова промяна

Celsion Corp Прогноза

Ценова цел

By TipRanks

669.23% нагоре

12-месечна прогноза

Среден 25 USD 669.23%

Висок 25 USD

Нисък 25 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Celsion Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Celsion Corp през последните 3 месеца.

Финанси

Относно Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.